Liesbeth Reneman

1. Research focus and ambition:

Application of non-invasive molecular neuroimaging techniques to advance Translational Neuroradiology in the broadest sense of the word (translations from structure to function, from invasive-to non-invasive, from animal to human, from group to individual and from adults to children). This unique and very innovative line of research provides insight into the risks of benefit and harm (evidence based medicine) of psychotropic drugs and medicines on the brain (in development) and its application in personalized medicine.

2. Research performance:
  • 102 peer reviewed publications. Hirsch index of 26 and ‘scientific age’ of 11 years.
  • Average impact factor (IF) = 5.2, the average IF of the field of research (Neuroimaging) is = 2.3
  • Various honors and awards, including: Fullbright OiO Grant (2000), Marie-Curie award (Society of Nuclear Medicine, 2000), PhD thesis cum laude (2001), Science Trophy (Hersenstichting Nederland 2001), ISMRM (2008, 2011, 2014, 2016).
  • > 50 invited international lectures and expert meetings (Ministry of Justice, NIDA, Advisory Council of the Misuse of Drugs).
  • Member Editorial Board Scientifica (Molecular Imaging area).

3. Research coordination
  • Coordinator of the ‘Translational Neuroradiology’ group, a multidisciplinary (psychiatry, neuropharmacology, neurology and basic neuroscience) translational line of research in close collaboration with UvA research priority program Amsterdam Brain and Cognition (ABC).
  • The ‘Translational Neuroradiology’ group currently consists of 6 investigators (5 PhD students, and 1 post doc).
  • (co-)Promotor of 10 completed PhD theses, and of another 6 PhD students scheduled until 2022.
  • Coordinator of several high impact grants in which phMRI is the working method of choice, including an EU FP6 project from ERA-NET PrioMedChild, and a TOP grant.
  • AMC Research Programme leader ‘Brain Imaging’ of the AMC‐UvA‐VUmc-VU ‘Neuroscience Amsterdam’ research organization together with D. Veltman (VUmc).

4. Fund raising
  • Totals to nearly 5 million since 2008, including: VENI (2008), AMC Fellowhsip (2008), KWF (2010 and 2013), FP6 ERA-NET PrioMedChild coordination (2011), TOP grant (2012), abc (2015) and Amsterdam Neuroscience (2016, 2017) and Hartstichting (2017) grants.

5. Teaching performance
  • Basis Kwalificatie Onderwijs (BKO) certified 2013.
  • Co-founder (2011) and daily manager of the Brain Imaging Center (BIC) at the AMC, involving guidance to and exchange between the educational activities of 90 PhD students and post docs in the disciplines of Psychiatry, Radiology, Nuclear Medicine, and Neurology.
  • Supervision of Bachelor and Master students (on average 5 per year).

6. International cooperation and contacts
  • Worked as a post doctoral research fellow for more than 3 years at top universities and laboratories abroad (UCLA, Johns Hopkins Medical Institutions, Imperial College).
  • Important ongoing international collaborations (e.g., Johns Hopkins University, Harvard Medical School, Hammersmith Hospital, King’s College, Oslo University, Istituto Italino di Tecnologia) resulting in exchange of PhD students, joint publications and international grants.
  • Founder (2014) of Pharmanetwork, a novel and highly multidisciplinary network, in which EU scientists are called to share, standardize and disseminate know-how, identify key opportunities for phMRI at healthcare level, and provide guidelines.